KORU Medical Systems, Inc. (NASDAQ:KRMD) Short Interest Update

KORU Medical Systems, Inc. (NASDAQ:KRMD - Get Free Report) was the target of a significant drop in short interest in the month of December. As of December 31st, there was short interest totalling 372,600 shares, a drop of 12.6% from the December 15th total of 426,400 shares. Based on an average daily volume of 67,100 shares, the days-to-cover ratio is presently 5.6 days. Currently, 0.9% of the company's stock are short sold.

Institutional Trading of KORU Medical Systems

A number of large investors have recently bought and sold shares of the stock. Geode Capital Management LLC grew its holdings in shares of KORU Medical Systems by 6.5% in the 3rd quarter. Geode Capital Management LLC now owns 462,128 shares of the company's stock worth $1,262,000 after purchasing an additional 28,323 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. increased its holdings in shares of KORU Medical Systems by 77.7% during the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 61,412 shares of the company's stock worth $168,000 after buying an additional 26,860 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of KORU Medical Systems in the second quarter valued at approximately $107,000. Meros Investment Management LP boosted its holdings in shares of KORU Medical Systems by 20.7% in the 2nd quarter. Meros Investment Management LP now owns 804,380 shares of the company's stock worth $2,132,000 after acquiring an additional 137,918 shares in the last quarter. Finally, XTX Topco Ltd bought a new stake in KORU Medical Systems during the 3rd quarter worth approximately $34,000. 58.60% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the stock. Lake Street Capital boosted their price target on shares of KORU Medical Systems from $4.00 to $5.00 and gave the company a "buy" rating in a report on Tuesday, January 14th. Craig Hallum lifted their target price on shares of KORU Medical Systems from $5.00 to $6.00 and gave the stock a "buy" rating in a report on Friday. Canaccord Genuity Group upped their price target on KORU Medical Systems from $3.00 to $4.00 and gave the stock a "buy" rating in a report on Thursday, November 14th. Finally, Piper Sandler lifted their target price on KORU Medical Systems from $3.00 to $3.50 and gave the stock an "overweight" rating in a research report on Thursday, November 14th. Four equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, KORU Medical Systems has an average rating of "Buy" and an average price target of $4.50.

KORU Medical Systems Price Performance

NASDAQ KRMD traded up $0.09 during trading on Friday, reaching $4.09. 192,961 shares of the company traded hands, compared to its average volume of 88,187. KORU Medical Systems has a 1-year low of $1.98 and a 1-year high of $4.60. The company has a market cap of $187.49 million, a price-to-earnings ratio of -16.36 and a beta of 0.45. The stock's 50 day moving average price is $3.82 and its two-hundred day moving average price is $2.98. The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.37 and a current ratio of 2.99.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.